HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 389143Generated: November 1, 2026
Water → 3-{1-[4-chloro-2-(methylsulfonyl)phenoxy]-1-methylethyl}-4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazole monohydrochloride
https://huagongshe.com/reaction/389143
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Sodium methanesulfinate | HCID 2733271 | — |
| Reactant | 3-[1-(2-bromo-4-chlorophenoxy)-1-methylethyl]-4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazole | HCID 58243845 | — |
| Catalyst | Copper iodide | HCID 83717 | — |
| Solvent | Dimethyl Sulfoxide | HCID 679 | — |
| Product | 3-{1-[4-chloro-2-(methylsulfonyl)phenoxy]-1-methylethyl}-4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazole monohydrochloride | HCID 67024415 | 16.7% |
Reaction Steps
A mixture of 3-[1-(2-bromo-4-chlorophenoxy)-1-methylethyl]-4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazole (200 mg), sodium methanesulfinate (215 mg) and copper iodide (400 mg) was dissolved in DMSO, followed by stirring under a nitrogen atmosphere at 110° C. for 4 hours and at 140° C. overnight. The reaction solution was returned to room temperature and water and ethyl acetate were added thereto, followed by celite filtration. The organic layer was separated from the filtrate, washed with saturated brine and dried over anhydrous magnesium sulfate, and the solvent was then evaporated under reduced pressure. The residue was purified by silica gel column chromatography (ethyl acetate:methanol=97:3) and further purified by thin layer chromatography (chloroform:methanol=97:3). The resulting residue was dissolved in ethyl acetate and 4M hydrogen chloride-ethyl acetate was added thereto, followed by stirring at room temperature for 30 minutes. The reaction solution was concentrated under reduced pressure. The resulting residue was crystallized by adding diisopropylether and collected by filtration to obtain 3-{1-[4-chloro-2-(methylsulfonyl)phenoxy]-1-methylethyl}-4-methyl-5-[2-(trifluoromethyl)phenyl]-4H-1,2,4-triazole monohydrochloride (18 mg) as a white crystal.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08377923B2 |
|---|
| Source dataset | uspto-grants-2013_02 |
|---|
| ORD ID | ord-41e58efaae874a3fb7b35031378da717 |
|---|
| Source note | uspto-grants-2013_02 |
|---|